|
--- |
|
language: |
|
- en |
|
bigbio_language: |
|
- English |
|
license: cc0-1.0 |
|
bigbio_license_shortname: CC0_1p0 |
|
multilinguality: monolingual |
|
pretty_name: CZI DRSM |
|
homepage: https://github.com/chanzuckerberg/DRSM-corpus |
|
bigbio_pubmed: false |
|
bigbio_public: true |
|
bigbio_tasks: |
|
- TXTCLASS |
|
--- |
|
|
|
# Dataset Card for CZI DRSM |
|
|
|
## Dataset Description |
|
|
|
- **Homepage:** https://github.com/chanzuckerberg/DRSM-corpus |
|
- **Pubmed:** False |
|
- **Public:** True |
|
- **Tasks:** TXTCLASS |
|
|
|
Research Article document classification dataset based on aspects of disease research. Currently, the dataset consists of three subsets: |
|
|
|
(A) classifies title/abstracts of papers into most popular subtypes of clinical, basic, and translational papers (~20k papers); |
|
|
|
- Clinical Characteristics, Disease Pathology, and Diagnosis: |
|
Text that describes (i) symptoms, signs, or ‘phenotype’ of a disease; |
|
(ii) the effects of the disease on patient organs, tissues, or cells; |
|
(iii)) the results of clinical tests that reveal pathology (including |
|
biomarkers); (iv) research that use this information to figure out |
|
a diagnosis. |
|
|
|
- Therapeutics in the clinic: |
|
Text describing how treatments work in the clinic (but not in a clinical trial). |
|
|
|
- Disease mechanism: |
|
|
|
- Patient-Based Therapeutics: |
|
Text describing (i) Clinical trials (studies of therapeutic measures being |
|
used on patients in a clinical trial); (ii) Post Marketing Drug Surveillance |
|
(effects of a drug after approval in the general population or as part of |
|
‘standard healthcare’); (iii) Drug repurposing (how a drug that has been |
|
approved for one use is being applied to a new disease). |
|
|
|
(B) identifies whether a title/abstract of a paper describes substantive research into Quality of Life (~10k papers); |
|
|
|
- [-1] - the paper is not a primary experimental study in rare disease |
|
|
|
- [0] - the study does not directly investigate quality of life |
|
|
|
- [1] - the study investigates qol but not as its primary contribution |
|
|
|
- [2] - the study's primary contribution centers on quality of life measures |
|
|
|
(C) identifies if a paper is a natural history study (~10k papers). |
|
|
|
- [-1] - the paper is not a primary experimental study in rare disease |
|
|
|
- [0] - the study is not directly investigating the natural history of a disease |
|
|
|
- [1] - the study includes some elements a natural history but not as its primary contribution |
|
|
|
- [2] - the study's primary contribution centers on observing the time course of a rare disease |
|
|
|
These classifications are particularly relevant in rare disease research, a field that is generally understudied. |
|
|
|
This data was compiled through the use of a gamified curation approach based on CentaurLabs' 'diagnos.us' platform. |
|
|
|
## Citation Information |
|
|
|
``` |
|
# N/A |
|
``` |
|
|
